PAUL MAI: Open Payments
NPI 1194362574 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,315 in 15 payments from 11 companies in 2025. Trend: 2023 $312 · 2024 $205 · 2025 $1,315
Food & beverage: $1,315
| Company | Payments | Amount |
|---|---|---|
| AOP Health US, LLC | 1 | $443 |
| Madrigal Pharmaceuticals | 3 | $322 |
| ConvaTec Inc. | 1 | $135 |
| Teva Pharmaceuticals USA, Inc. | 1 | $112 |
| ACADIA Pharmaceuticals Inc | 1 | $67 |
| BridgeBio Pharma, Inc. | 2 | $52 |
| Kestra Medical Technology Services, Inc. | 1 | $49 |
| AstraZeneca Pharmaceuticals LP | 2 | $46 |
| ABIOMED | 1 | $44 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $28 |
Products named: Rapiblyk, REZDIFFRA, AQUACEL AG+ EXTRA, NUPLAZID, Attruby, Assure WCD, LOKELMA, JARDIANCE.
Industry payments across NY — which companies pay providers there.
